Imaging stocks continue to struggle

Article

Public companies providing imaging devices and services continue to have a hard time making money for their shareholders, according to data from a recent industry survey by HealthCare Markets Group. Shares of imaging device manufacturers fell 4.6% in the

Public companies providing imaging devices and services continue to have a hard time making money for their shareholders, according to data from a recent industry survey by HealthCare Markets Group. Shares of imaging device manufacturers fell 4.6% in the first nine months of 1999 (end-September), compared to a 21% drop for the same period in 1998.

Among the biggest gainers were Vital Images, up 170%, and SonoSite, up 152%; the biggest losses were felt by Hologic, down 67%, and Fischer Imaging, down 56%.

Share price for imaging services vendors declined 5.8% during the first nine months of 1999, compared to a 32% decline for all of 1998. Overall, healthcare industry stock prices declined 2.8% in the first nine months of 1999, compared to a 1.9% increase in the same period of 1998.

Despite the poor performance, 1999 is still turning out to be a better year than 1998, which witnessed a 23% decline in share value for imaging device firms (SCAN 1/13/99). HMG of Hilton Head, SC, reviews the financial performance of publicly owned healthcare companies in 36 market segments.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.